RA Capital's big Covid bet
From Institutional Investor: Little-known health care hedge fund firm RA Capital Management raised its profile Monday when it shelled out $200 million to invest in Novavax, a late-stage biotechnology company developing a vaccine for Covid-19. RA Capital bought Series A co...